Healthcare -
Biotechnology - NASDAQ - US
$ 4.41
-2.65 %
$ 204 M
Market Cap
-1.55
P/E
FDMT - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative FDMT - 4D Molecular Therapeutics, Inc.
36.5 M
LAST VALUE
14.14%
2 YEAR CAGR
42.70%
5 YEAR CAGR
0.00%
10 YEAR CAGR